XML 103 R78.htm IDEA: XBRL DOCUMENT v3.25.4
STOCK-BASED COMPENSATION AND EMPLOYEE RETIREMENT PLANS - Equity Plans (Details) - shares
Dec. 31, 2025
Jun. 10, 2025
Dec. 31, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of options outstanding (in shares) 18,152,258   16,684,325
Inducement Award Program      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of options outstanding (in shares) 1,152,477    
Keryx Equity Plans      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Awards outstanding (in shares) 148,860   163,765
Additional awards authorized for grant (in shares) 0   0
Akebia Therapeutics, Inc. 2014 Incentive Plan, as amended (the 2014 Plan)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Awards outstanding (in shares) 8,412,898   11,559,708
Additional awards authorized for grant (in shares) 0   0
Akebia Therapeutics, Inc. 2014 Incentive Plan, as amended (the 2014 Plan) | Inducement Award Program      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of options outstanding (in shares) 1,050,525   1,151,127
Akebia Therapeutics, Inc. 2023 Stock Incentive Plan (the 2023 Plan) (replaces 2014 Plan), as amended      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Awards outstanding (in shares) 15,913,729   10,390,642
Additional awards authorized for grant (in shares) 24,723,655   11,340,648
Akebia Therapeutics, Inc. 2023 Stock Incentive Plan (the 2023 Plan) (replaces 2014 Plan), as amended | Inducement Award Program      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Additional awards authorized for grant (in shares)   18,900,000  
Number of options outstanding (in shares) 3,034,085   2,534,775